Genfit SA (GNFT)
4.18
-0.06
(-1.42%)
USD |
NASDAQ |
Nov 22, 11:00
Genfit 1 Year Total Returns (Daily): 32.92% for Nov. 21, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 21, 2024 | 32.92% |
November 20, 2024 | 30.61% |
November 19, 2024 | 30.76% |
November 18, 2024 | 34.05% |
November 15, 2024 | 36.36% |
November 14, 2024 | 33.38% |
November 13, 2024 | 60.31% |
November 12, 2024 | 60.71% |
November 11, 2024 | 61.28% |
November 08, 2024 | 59.45% |
November 07, 2024 | 72.51% |
November 06, 2024 | 73.80% |
November 05, 2024 | 77.34% |
November 04, 2024 | 76.42% |
November 01, 2024 | 94.79% |
October 31, 2024 | 78.90% |
October 30, 2024 | 86.90% |
October 29, 2024 | 76.81% |
October 28, 2024 | 76.81% |
October 25, 2024 | 85.19% |
October 24, 2024 | 83.88% |
October 23, 2024 | 87.43% |
October 22, 2024 | 96.24% |
October 21, 2024 | 94.60% |
October 18, 2024 | 90.38% |
Date | Value |
---|---|
October 17, 2024 | 103.5% |
October 16, 2024 | 99.05% |
October 15, 2024 | 84.11% |
October 14, 2024 | 90.34% |
October 11, 2024 | 87.62% |
October 10, 2024 | 78.45% |
October 09, 2024 | 85.00% |
October 08, 2024 | 75.27% |
October 07, 2024 | 71.35% |
October 04, 2024 | 77.17% |
October 03, 2024 | 72.64% |
October 02, 2024 | 64.93% |
October 01, 2024 | 54.83% |
September 30, 2024 | 82.57% |
September 27, 2024 | 73.25% |
September 26, 2024 | 71.56% |
September 25, 2024 | 67.60% |
September 24, 2024 | 57.61% |
September 23, 2024 | 48.96% |
September 20, 2024 | 30.11% |
September 19, 2024 | 17.70% |
September 18, 2024 | 21.57% |
September 17, 2024 | 11.32% |
September 16, 2024 | 8.82% |
September 13, 2024 | 2.76% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-80.91%
Minimum
May 11 2021
103.5%
Maximum
Oct 17 2024
-17.91%
Average
-15.21%
Median
Jul 27 2023
1 Year Total Returns (Daily) Benchmarks
Edap TMS SA | -44.04% |
DBV Technologies SA | -69.87% |
Cellectis SA | -34.51% |
Adaptimmune Therapeutics PLC | 44.19% |
Akari Therapeutics PLC | -59.35% |